Tag: Continuous Glucose Monitor (CGM)

WASHINGTON – The House Energy & Commerce Committee on Dec. 6 approved an amended version of H.R. 5555 that extends the 75/25 blended rate in non-competitive bidding areas through 2024.   The amended language does not, however, include the 90/10 blended rate adjustment for suppliers in former CBAs, according to a bulletin from AAHomecare.   The Senate Finance Committee included similar 75/25 language from S. 1294 in a health package in November.   “This...

WASHINGTON – The Office of Inspector General has added to its work plan a review of Medicare payments for continuous glucose monitors and sensors and how they compare to prices available to consumers. The agency will compare Medicare payments to supplier acquisition costs and prices otherwise available to consumers for selected CGMs and their sensors to determine if there are potential cost savings for Medicare and enrollees. In 2022, Medicare Part B allowed more than $1.1 billion in payments...

YARMOUTH, Maine – The end of Medicare’s competitive bidding program for knee and back braces on Dec. 31 could open the door to increased audit activity for orthotics in 2024, industry consultants predict.  “We’ve already seen the Supplemental Medical Review Contractor (SMRC) add braces back onto their project list and the Recovery Audit Contractor (RAC) still has them on their approved list,” said Kelly Grahovac, general manager of the van Halem Group. “But...

PARSIPPANY, N.J., and GERMANTOWN, Md. – Ascensia Diabetes Care and Senseonics Holdings have launched a new U.S. advertising and marketing campaign for the Eversense E3 CGM System. The “CGM for Real Life” campaign seeks to drive awareness of the Eversense E3, a six-month, implantable sensor, as well as the everyday challenges people with diabetes face. “This campaign is designed to challenge the status quo in continuous glucose monitoring, which for too long has meant self-insertion...

RICHFIELD, Minn. – Best Buy will sell the Dexcom G7 continuous glucose monitoring system (CGM) to eligible customers through BestBuy.com, where they will be brought to a new platform, Wellness.BestBuyHealth.com, to complete the process.  It’s the first time the electronics giant will offer prescription-based medical devices to customers.  “Through our health and wellness categories at Best Buy, we make it easy to purchase any of our thousands of carefully curated...

ABBOTT PARK, Ill., and NEW YORK – Abbott and WeightWatchers have announced the availability of a connected app to help people living with diabetes understand how food and activity impact their glucose levels. WW members who follow the WW Diabetes-Tailored Plan can now access their glucose data from Abbott’s FreeStyle Libre 2, a continuous glucose monitoring system, within their WW app. "Clinical data shows that healthy weight loss leads to a reduction of average glucose, which is important...

PARSIPPANY, N.J. – Ascensia Diabetes Care, owner of the CONTOUR blood glucose monitoring system portfolio and exclusive distributor of the Eversense continuous glucose monitoring system, has opened submissions for its art and photo competition in support of World Diabetes Day 2023. The theme of this year’s competition is “This is Diabetes, This is Real,” aiming to capture the challenges, successes and day-to-day realities of people living with diabetes. “For our 2023...

SANTA MONICA, Calif. - GoodRx says it has helped almost 2.5 million Americans save more than $500 million on diabetes treatments to date. The company says, for example, that its customers saved, on average, 37% on continuous glucose monitors, including the Dexcom G6 and G7, FreeStyle Libre, Libre 2 and Libre 3. “Managing a chronic condition can be incredibly expensive and time consuming – so much so, we’ve seen the cost of supplies and prescriptions used to manage diabetes...

We’ve burned through the first half of 2023 already and what do we have to show for it?  If the most read stories from January through June are any indication, it’s disruption, innovation and growth.  Let’s start with disruption. It has come in a number of forms in 2023, including one of the HME industry’s legacy manufacturers, Invacare, filing for bankruptcy. We posted a story about that to our website in February, and it remains the most read story of the...

PLYMOUTH MEETING, Pa. - AdaptHealth’s board of directors has named Lincare’s Crispin Teufel as its next CEO.  Teufel, who has served as CEO of Lincare since July 2017, is expected to assume his role at AdaptHealth on Sept. 1.  “We are quite pleased to be announcing the appointment of Crispin Teufel as the next CEO of AdaptHealth,” said Richard Barasch, chairman of the board. “Crispin is the ideal candidate to lead AdaptHealth in its mission to transform...